These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34307919)

  • 21. Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy.
    Bohoudi O; Bruynzeel AME; Meijerink MR; Senan S; Slotman BJ; Palacios MA; Lagerwaard FJ
    Radiother Oncol; 2019 Mar; 132():16-22. PubMed ID: 30825964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.
    Werensteijn-Honingh AM; Kroon PS; Winkel D; van Gaal JC; Hes J; Snoeren LMW; Timmer JK; Mout CCP; Bol GH; Kotte AN; Eppinga WSC; Intven M; Raaymakers BW; Jürgenliemk-Schulz IM
    Phys Imaging Radiat Oncol; 2022 Jul; 23():66-73. PubMed ID: 35814260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance.
    Gani C; Boeke S; McNair H; Ehlers J; Nachbar M; Mönnich D; Stolte A; Boldt J; Marks C; Winter J; Künzel LA; Gatidis S; Bitzer M; Thorwarth D; Zips D
    Clin Transl Radiat Oncol; 2021 Jan; 26():55-61. PubMed ID: 33319073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic body radiotherapy of central lung tumours using a 1.5 T MR-linac: First clinical experiences.
    Merckel LG; Pomp J; Hackett SL; van Lier ALHMW; van den Dobbelsteen M; Rasing MJA; Mohamed Hoesein FAA; Snoeren LMW; van Es CA; van Rossum PSN; Fast MF; Verhoeff JJC
    Clin Transl Radiat Oncol; 2024 Mar; 45():100744. PubMed ID: 38406645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations.
    Placidi L; Romano A; Chiloiro G; Cusumano D; Boldrini L; Cellini F; Mattiucci GC; Valentini V
    Tech Innov Patient Support Radiat Oncol; 2020 Sep; 15():15-21. PubMed ID: 32642565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5 T MR-Linac.
    Muinck Keizer DM; Willigenburg T; der Voort van Zyp JRN; Raaymakers BW; Lagendijk JJW; Boer JCJ
    Radiother Oncol; 2021 Sep; 162():162-169. PubMed ID: 34293410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the impact of patient arm position in an MR-linac on liver SBRT treatment plans.
    van den Wollenberg W; de Ruiter P; Nowee ME; Jansen EPM; Sonke JJ; Fast MF
    Med Phys; 2019 Nov; 46(11):5144-5151. PubMed ID: 31529694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.
    Intven MPW; de Mol van Otterloo SR; Mook S; Doornaert PAH; de Groot-van Breugel EN; Sikkes GG; Willemsen-Bosman ME; van Zijp HM; Tijssen RHN
    Radiother Oncol; 2021 Jan; 154():172-178. PubMed ID: 32976875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
    Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI-based inter- and intrafraction motion analysis of the pancreatic tail and spleen as preparation for adaptive MRI-guided radiotherapy in neuroblastoma.
    Van Ommen F; le Quellenec GAT; Willemsen-Bosman ME; van Noesel MM; van den Heuvel-Eibrink MM; Seravalli E; Kroon PS; Janssens GO
    Radiat Oncol; 2023 Oct; 18(1):160. PubMed ID: 37784151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying predictors of on-table adaptation for pancreas stereotactic body radiotherapy (SBRT).
    Wu TC; Yoon SM; Cao M; Raldow AC; Xiang M
    Clin Transl Radiat Oncol; 2023 May; 40():100603. PubMed ID: 36896266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Planning target volume margin assessment for online adaptive MR-guided dose-escalation in rectal cancer on a 1.5 T MR-Linac.
    Eijkelenkamp H; Boekhoff MR; Verweij ME; Peters FP; Meijer GJ; Intven MPW
    Radiother Oncol; 2021 Sep; 162():150-155. PubMed ID: 34280404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrafraction pancreatic tumor motion patterns during ungated magnetic resonance guided radiotherapy with an abdominal corset.
    Grimbergen G; Eijkelenkamp H; Heerkens HD; Raaymakers BW; Intven MPW; Meijer GJ
    Phys Imaging Radiat Oncol; 2022 Jan; 21():1-5. PubMed ID: 35005257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motion and dosimetric criteria for selecting gating technique for apical lung lesions in magnetic resonance guided radiotherapy.
    Galetto M; Nardini M; Capotosti A; Meffe G; Cusumano D; Boldrini L; Chiloiro G; Romano A; Votta C; Gambacorta MA; Indovina L; Placidi L
    Front Oncol; 2023; 13():1280845. PubMed ID: 38074641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric Feasibility of Utilizing the ViewRay Magnetic Resonance Guided Linac System for Image-guided Spine Stereotactic Body Radiation Therapy.
    Redler G; Stevens T; Cammin J; Malin M; Green O; Mutic S; Pitroda S; Aydogan B
    Cureus; 2019 Dec; 11(12):e6364. PubMed ID: 31938646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individual lymph nodes: "See it and Zap it".
    Winkel D; Werensteijn-Honingh AM; Kroon PS; Eppinga WSC; Bol GH; Intven MPW; de Boer HCJ; Snoeren LMW; Hes J; Raaymakers BW; Jürgenliemk-Schulz IM
    Clin Transl Radiat Oncol; 2019 Sep; 18():46-53. PubMed ID: 31341975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
    Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
    Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosimetric and motion analysis of margin-intensive therapy by stereotactic ablative radiotherapy for resectable pancreatic cancer.
    Heinzerling JH; Bland R; Mansour JC; Schwarz RE; Ramirez E; Ding C; Abdulrahman R; Boike TP; Solberg T; Timmerman RD; Meyer JJ
    Radiat Oncol; 2011 Oct; 6():146. PubMed ID: 22035405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac.
    Dang J; Kong V; Li W; Navarro I; Winter JD; Malkov V; Berlin A; Catton C; Padayachee J; Raman S; Warde P; Chung P
    Tech Innov Patient Support Radiat Oncol; 2022 Sep; 23():41-46. PubMed ID: 36105770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-time 4D MRI using MR signature matching (MRSIGMA) on a 1.5T MR-Linac system.
    Wu C; Murray V; Siddiq SS; Tyagi N; Reyngold M; Crane C; Otazo R
    Phys Med Biol; 2023 Sep; 68(18):. PubMed ID: 37619588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.